InMed Pharmaceuticals reported cash from operations of -$1.70M and free cash flow of -$1.70M for the quarter ended Mar 2026, down 2.1% year over year. This cash flow statement covers 27 quarters of results from Sep 2019 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||
| Net Income | -2.97M | -4.28M | -3.48M | -7.87M | -3.51M | -2.10M | -2.00M | -0.34M | -2.54M | -1.48M | -1.72M | -1.93M | -1.68M | -2.58M | -2.12M | -1.31M | -1.73M | -2.03M | -2.97M | ||||||||
| Depreciation and DepletionDep. & Depletion | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | ||||||||||||||||||
| Share-based CompensationStock Comp. | 0.22M | 0.11M | 0.21M | 0.20M | 2.49M | 0.12M | 0.07M | 0.05M | 1.00 | 0.10M | 0.63M | 0.68M | -0.03M | 0.06M | 0.06M | -0.06M | 0.06M | 0.20M | 0.19M | ||||||||
| Asset Writedowns and ImpairmentWritedown | 0.58M | -0.27M | 0.09M | 0.17M | 0.04M | 0.21M | 0.21M | ||||||||||||||||||||
| Cash from OperationsCash from Ops. | -2.01M | -2.65M | -3.53M | -5.35M | -4.05M | -2.26M | -2.71M | -1.66M | -0.66M | -2.17M | -1.85M | -1.93M | -1.03M | -1.83M | -2.50M | -1.66M | -1.78M | -1.61M | -2.38M | -1.70M | |||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.10M | 0.09M | 0.09M | 0.10M | 0.09M | 0.09M | 0.10M | 0.10M | 0.09M | 0.08M | 0.08M | 0.08M | 0.10M | 0.10M | 0.08M | ||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.03M | 0.03M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | |||||||
| Change in Working Capital | |||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -0.06M | 0.00M | -638.00 | 0.02M | 0.02M | -0.07M | 0.09M | 0.09M | 0.11M | -0.09M | 0.21M | -0.17M | 0.15M | -0.07M | -0.02M | 0.11M | 0.10M | -0.12M | -0.16M | ||||||||
| Change in InventoryChange Inventory | 0.43M | 1.07M | -0.14M | -0.17M | -0.28M | 0.02M | -0.39M | -0.22M | 0.45M | 0.09M | -0.02M | -0.12M | -0.29M | 0.15M | -0.07M | 0.13M | |||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.58M | -0.47M | 0.77M | -0.49M | -0.62M | -0.16M | -0.35M | -0.08M | -0.22M | -0.56M | 0.24M | -0.10M | 0.47M | -0.64M | 0.36M | -0.07M | 0.10M | -0.27M | -0.06M | 0.11M | |||||||
| Other Working Capital ChangesOther WC Changes | -0.02M | 0.03M | -0.03M | -0.33M | 0.50M | -0.13M | 0.47M | ||||||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.25M | -0.21M | 0.00M | 0.02M | -0.01M | 0.13M | 0.03M | -0.00M | 0.01M | 2.00 | |||||||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | |||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 0.02M | 0.02M | -431.00 | 0.02M | 0.00M | 0.02M | 0.00M | 0.02M | 0.00M | 0.02M | |||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.25M | 0.31M | -0.00M | -0.73M | -0.13M | -0.03M | -2.00 | ||||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.08M | 1.12M | 0.18M | 0.49M | 0.57M | 10.17M | -0.06M | -646.00 | 1.00 | 1.03M | 0.40M | 2.94M | 3.77M | ||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.08M | 10.88M | -0.84M | -0.03M | 5.05M | 5.43M | 5.32M | -0.06M | 176.00 | 0.84M | 0.34M | 2.92M | 8.17M | -0.14M | 0.23M | ||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.06M | 509.00 | 0.03M | 0.03M | 0.00M | ||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 12.00M | 176.00 | 5.15M | 6.00M | 6.00M | 174.00 | |||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | |||||||||||||||||||||||||||
| Change in Cash | -2.09M | 7.98M | -4.06M | -5.38M | 0.28M | 3.17M | 2.10M | -1.85M | -0.69M | -2.17M | 2.80M | -1.93M | -1.03M | -0.99M | -2.16M | 1.26M | 6.40M | -1.74M | -2.38M | -1.46M | |||||||
| Free Cash FlowFCF | -2.01M | -2.90M | -3.32M | -5.35M | -4.07M | -2.25M | -2.71M | -1.79M | -0.69M | -2.17M | -1.86M | -1.93M | -1.03M | -1.83M | -2.50M | -1.66M | -1.78M | -1.61M | -2.38M | -1.70M | |||||||
| Net Cash FlowNCF | -2.09M | 7.98M | -4.06M | -5.38M | 0.28M | 3.17M | 2.60M | -1.85M | -0.69M | -2.17M | -1.85M | -1.93M | -1.03M | -0.99M | -2.16M | 1.26M | 6.40M | -1.74M | -2.38M | -1.46M |